Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Eye of the Storm: COVID-19 Vaccination and the Eye.
Ng XL, Betzler BK, Ng S, Chee SP, Rajamani L, Singhal A, Rousselot A, Pavesio CE, Gupta V, de Smet MD, Agrawal R. Ng XL, et al. Among authors: de smet md. Ophthalmol Ther. 2022 Feb;11(1):81-100. doi: 10.1007/s40123-021-00415-5. Epub 2021 Dec 16. Ophthalmol Ther. 2022. PMID: 34914035 Free PMC article. Review.
COVID-19: Limiting the Risks for Eye Care Professionals.
Sadhu S, Agrawal R, Pyare R, Pavesio C, Zierhut M, Khatri A, Smith JR, de Smet MD, Biswas J. Sadhu S, et al. Among authors: de smet md. Ocul Immunol Inflamm. 2020 Jul 3;28(5):714-720. doi: 10.1080/09273948.2020.1755442. Epub 2020 Apr 20. Ocul Immunol Inflamm. 2020. PMID: 32310028 Review.
COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.
Thng ZX, De Smet MD, Lee CS, Gupta V, Smith JR, McCluskey PJ, Thorne JE, Kempen JH, Zierhut M, Nguyen QD, Pavesio C, Agrawal R. Thng ZX, et al. Among authors: de smet md. Br J Ophthalmol. 2021 Mar;105(3):306-310. doi: 10.1136/bjophthalmol-2020-316586. Epub 2020 Jun 12. Br J Ophthalmol. 2021. PMID: 32532764 Free PMC article. Review.
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.
Agrawal R, Testi I, Lee CS, Tsui E, Blazes M, Thorne JE, Okada AA, Smith JR, McCluskey PJ, Kempen JH, Tappeiner C, Agarwal M, Bodaghi B, Nguyen QD, Gupta V, De Smet MD, Zierhut M, Pavesio C; COVID-19 IMT Study Group. Agrawal R, et al. Among authors: de smet md. Br J Ophthalmol. 2021 May;105(5):639-647. doi: 10.1136/bjophthalmol-2020-316776. Epub 2020 Jun 25. Br J Ophthalmol. 2021. PMID: 32586933 Free PMC article.
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis.
Agrawal R, Testi I, Bodaghi B, Barisani-Asenbauer T, McCluskey P, Agarwal A, Kempen JH, Gupta A, Smith JR, de Smet MD, Yuen YS, Mahajan S, Kon OM, Nguyen QD, Pavesio C, Gupta V; Collaborative Ocular Tuberculosis Study Consensus Group. Agrawal R, et al. Among authors: de smet md. Ophthalmology. 2021 Feb;128(2):277-287. doi: 10.1016/j.ophtha.2020.06.052. Epub 2020 Jun 27. Ophthalmology. 2021. PMID: 32603726
Ocular Adverse Events After COVID-19 Vaccination.
Ng XL, Betzler BK, Testi I, Ho SL, Tien M, Ngo WK, Zierhut M, Chee SP, Gupta V, Pavesio CE, de Smet MD, Agrawal R. Ng XL, et al. Among authors: de smet md. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1216-1224. doi: 10.1080/09273948.2021.1976221. Epub 2021 Sep 24. Ocul Immunol Inflamm. 2021. PMID: 34559576 Free PMC article. Review.
The Role of Corticosteroids and Immunomodulatory Therapy in the Management of Infectious Uveitis.
Akhavanrezayat A, Uludag Kirimli G, Matsumiya W, Khojasteh H, Or C, Karaca I, Pham B, Ongpalakorn P, Lajevardi S, Lam B, Hwang JJ, Than NTT, Park S, Yavari N, Bazojoo V, Mobasserian A, Khatri A, Halim MS, Thng ZX, Ghoraba H, Do DV, Tugal-Tutkun I, Gupta V, de Smet M, Nguyen QD. Akhavanrezayat A, et al. Ocul Immunol Inflamm. 2024 Oct;32(8):1832-1843. doi: 10.1080/09273948.2023.2296032. Epub 2024 Feb 8. Ocul Immunol Inflamm. 2024. PMID: 38330155 Review.
Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU):: The Phase 2 SATURN Study.
Heissigerová J, Callanan D, de Smet MD, Srivastava SK, Karkanová M, Garcia-Garcia O, Kadayifcilar S, Ozyazgan Y, Vitti R, Erickson K, Athanikar A, Chu K, Saroj N, Sundaram PA, Varona R, Corp-Dit-Genti V, Buggage R, Cheng Y, Soo Y, Nguyen QD. Heissigerová J, et al. Among authors: de smet md. Ophthalmology. 2019 Mar;126(3):428-437. doi: 10.1016/j.ophtha.2018.09.044. Epub 2018 Oct 11. Ophthalmology. 2019. PMID: 30316888 Clinical Trial.
199 results